Michael Shawn Moran - Jan 31, 2022 Form 4 Insider Report for EAGLE PHARMACEUTICALS, INC. (EGRX)

Role
EVP, Chief Commercial Officer
Signature
/s/ Brian Cahill, Attorney-in-Fact
Stock symbol
EGRX
Transactions as of
Jan 31, 2022
Transactions value $
-$9,647
Form type
4
Date filed
2/1/2022, 05:46 PM
Previous filing
Jan 11, 2022
Next filing
Feb 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EGRX Common Stock Tax liability -$9.65K -210 -0.93% $45.94 22.5K Jan 31, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld to satisfy withholding tax obligations.